CDK7

UniProt ID: P50613
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

CDK7 is a CMGC-family serine/threonine protein kinase that, with cyclin H and the RING-finger assembly factor MAT1, forms the trimeric CDK-activating kinase (CAK). In this complex it phosphorylates the activation-loop (T-loop) threonine of cell-cycle CDKs, including CDK1, CDK2, CDK4 and CDK6, and is the principal CAK of metazoan cells, required to establish CDK1/CDK2 activity and to maintain CDK4/CDK6 activity during G1. The same trimer is the TFIIK kinase module of the general transcription factor TFIIH, where CDK7 phosphorylates Ser5 and Ser7 of the RNA polymerase II CTD heptad repeats at promoters during initiation and promoter escape, promoting capping-enzyme recruitment, promoter-proximal pausing and, through T-loop phosphorylation of CDK9 and phosphorylation of SPT5, the transition to productive elongation. Other substrates include p53 (Ser33). CDK7 is predominantly nuclear, with a minor cytoplasmic pool. It is a conserved single-copy ortholog across eukaryotes (Kin28 in budding yeast, Mcs6 in fission yeast).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000307 cyclin-dependent protein kinase holoenzyme complex
IDA
PMID:23622515
A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progr...
ACCEPT
Summary: ComplexPortal annotation of CDK7 to the cyclin-dependent kinase holoenzyme (the CDK7-cyclin H-MAT1 CAK trimer).
Reason: CDK7 is the catalytic subunit of the trimeric CAK, a cyclin-CDK holoenzyme; the cited paper states this directly and uses the trimer as the physiological CAK for CDK4/6.
Supporting Evidence:
PMID:23622515
The sole CAK identified in metazoans is itself a CDK, Cdk7, which forms trimeric complexes with cyclin H and the RING-finger protein Mat1
file:human/CDK7/CDK7-uniprot.txt
Catalytic subunit of the CDK-activating kinase (CAK) complex, a master
GO:0000439 transcription factor TFIIH core complex
IDA
PMID:8692841
Isolation and characterization of two human transcription fa...
MODIFY
Summary: CDK7 annotated to the TFIIH core complex based on fractionation of TFIIH-related complexes.
Reason: The cited abstract shows the opposite: the core TFIIH* subcomplex is devoid of CAK, whereas CDK7 co-purifies with XPD in ERCC2/CAK, which joins TFIIH* to form the holoenzyme. CDK7 belongs to the CAK/TFIIK module of holo-TFIIH, not to core TFIIH. The location claim is better expressed by the holo complex and CAK-ERCC2 complex terms, both of which the gene already carries.
Supporting Evidence:
PMID:8692841
TFIIH* consists of a subset of the TFIIH complex proteins including ERCC3 (XPB), p62, p44, p41, and p34 but is devoid of detectable levels of ERCC2 (XPD) and CAK
PMID:8692841
ERCC2/CAK was isolated as a complex that exhibits CAK activity that cosediments with the three CAK components (cdk7, cyclin H, and p36/MAT1) as well as the ERCC2 (XPD) protein
GO:0001650 fibrillar center
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: Human Protein Atlas immunofluorescence places CDK7 in nucleolar fibrillar centers.
Reason: Plausible because TFIIH also functions in RNA polymerase I transcription (Reactome lists CDK7-containing TFIIH in Pol I promoter-escape and elongation events), but this is a minor, antibody-based localization and peripheral to the core nucleoplasmic roles.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
GO:0004672 protein kinase activity
IEA
GO_REF:0000120
MODIFY
Summary: Electronic protein kinase activity for CDK7.
Reason: Correct but less specific than the evidence: CDK7 is a cyclin-dependent protein kinase that phosphorylates CDK T-loops and the Pol II CTD. Replace with the specific activities already carried by the gene.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
Catalytic subunit of the CDK-activating kinase (CAK) complex, a master
file:human/CDK7/CDK7-uniprot.txt
II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive
GO:0004672 protein kinase activity
TAS
PMID:7533895
Cdk-activating kinase complex is a component of human transc...
MODIFY
Summary: Protein kinase activity based on the identification of CAK as the TFIIH CTD kinase.
Reason: The paper shows CTD phosphorylation by Cdk7-cyclin H in the preinitiation complex and Cdc2/Cdk2 phosphorylation by TFIIH, which support the more specific CTD kinase and cyclin-dependent kinase terms.
Supporting Evidence:
PMID:7533895
both cyclin H and Cdk7 antibodies inhibit phosphorylation of the CTD of the largest subunit of the RNAPII in the preinitiation complex
PMID:7533895
TFIIH was shown to phosphorylate both Cdc2 and Cdk2
GO:0004674 protein serine/threonine kinase activity
IEA
GO_REF:0000107
MODIFY
Summary: Electronic (ortholog-transfer) protein serine/threonine kinase activity.
Reason: True but general; CDK7's serine/threonine kinase activity is specifically cyclin-dependent and directed at CDK T-loops and the Pol II CTD.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
Catalytic subunit of the CDK-activating kinase (CAK) complex, a master
file:human/CDK7/CDK7-uniprot.txt
II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive
GO:0004674 protein serine/threonine kinase activity
TAS
Reactome:R-HSA-6810233
MODIFY
Summary: Reactome reaction in which CDK7 phosphorylates CTD Ser5 and Ser7 at snRNA promoters.
Reason: The reaction describes CTD Ser5 and Ser7 kinase activity, for which specific GO terms exist.
Supporting Evidence:
Reactome:R-HSA-6810233
CDK7 phosphorylates serine-5 residues of heptad repeats (consensus YSPTSPS) in the C-terminal domain (CTD) of the large subunit (POLR2A) of RNA polymerase II
Reactome:R-HSA-6810233
CDK7 is required for phosphorylation of serine-7 in vivo
GO:0004674 protein serine/threonine kinase activity
TAS
Reactome:R-HSA-77071
MODIFY
Summary: Reactome reaction 'Phosphorylation (Ser5) of RNA pol II CTD'.
Reason: The reaction is Ser5 CTD phosphorylation, which maps to the specific CTD S5 kinase term.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive
PMID:26257281
Cdk7 phosphorylates Ser5 and Ser7 residues, the first of several CTD phosphorylation and dephosphorylation events during the transcription cycle
GO:0004693 cyclin-dependent protein serine/threonine kinase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference of cyclin-dependent protein serine/threonine kinase activity.
Reason: The IBA derives from PAINT node PANTHER:PTN000624096, the eukaryote-wide CDK7 ortholog clade of PTHR24056 (members include S. cerevisiae Kin28, S. pombe Mcs6 [SPBC19F8.07], Drosophila Cdk7 and rat Cdk7); human CDK7 sits inside this clade (UniProt PTHR24056:SF0) and has its own experimental support, so its appearance among the donors is expected, not circular. CDK7 requires cyclin H (and MAT1) for activity and phosphorylates CDK T-loops, matching the term.
Supporting Evidence:
PMID:15530371
For maximum activity and stability, CDK7 requires phosphorylation, association with cyclin H, and association with a third protein, MAT1
PMID:23622515
Here we analyze activation of Cdk4 and Cdk6 in Cdk7as cells, and show that Cdk7 is a physiologic CAK for both cyclin D-dependent kinases
GO:0004693 cyclin-dependent protein serine/threonine kinase activity
IEA
GO_REF:0000003
ACCEPT
Summary: EC-mapping-based cyclin-dependent kinase activity.
Reason: Consistent with the experimental CAK activity of CDK7-cyclin H-MAT1.
Supporting Evidence:
PMID:15530371
For maximum activity and stability, CDK7 requires phosphorylation, association with cyclin H, and association with a third protein, MAT1
file:human/CDK7/CDK7-uniprot.txt
mediators of cell cycle control, including CDK1, CDK2, CDK4 and CDK6,
GO:0004693 cyclin-dependent protein serine/threonine kinase activity
TAS
PMID:8208544
Two novel human serine/threonine kinases with homologies to ...
ACCEPT
Summary: Cyclin-dependent kinase activity traced to the cloning of human MO15/STK1.
Reason: The cloning paper itself infers function from 86% identity to Xenopus MO15, the known CAK; the activity is independently established for human CDK7, so the term stands.
Supporting Evidence:
PMID:8208544
STK1 is 86% identical to the Xenopus p40mo15, a cdc2-related serine/threonine kinase recently found to be the activating kinase for p34cdc2 and p33cdk2
PMID:23622515
Here we analyze activation of Cdk4 and Cdk6 in Cdk7as cells, and show that Cdk7 is a physiologic CAK for both cyclin D-dependent kinases
GO:0005515 protein binding
IPI
PMID:10801852
Distinct regions of MAT1 regulate cdk7 kinase and TFIIH tran...
REMOVE
Summary: Protein binding (IPI) with MAT1 (MNAT1).
Reason: MAT1 is a CAK subunit; the association is captured by the TFIIK/CAK complex annotations. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
Supporting Evidence:
PMID:10801852
the C terminus of MAT1 binds to the cdk7 x cyclin H complex and activates the cdk7 kinase activity
GO:0005515 protein binding
IPI
PMID:10958787
Interactions of Cdk7 and Kin28 with Hint/PKCI-1 and Hnt1 his...
REMOVE
Summary: Protein binding (IPI) with HINT1.
Reason: The HINT1 association has no defined CDK7 activity attached to it. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005515 protein binding
IPI
PMID:15530371
The crystal structure of human CDK7 and its protein recognit...
REMOVE
Summary: Protein binding (IPI) with CDK2.
Reason: CDK2 is a CAK substrate; the relationship is captured by the cyclin-dependent kinase activity annotation. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
Supporting Evidence:
PMID:15530371
For maximum activity and stability, CDK7 requires phosphorylation, association with cyclin H, and association with a third protein, MAT1
GO:0005515 protein binding
IPI
PMID:16327805
Dichotomous but stringent substrate selection by the dual-fu...
REMOVE
Summary: Protein binding (IPI) with a substrate (SUPT5H, CDK4 or CDK2) from the analog-sensitive kinase screen.
Reason: The partners are substrates, captured by the kinase activity annotations. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
Supporting Evidence:
PMID:16327805
proteins such as Pol II and transcription elongation factor Spt5, recognized efficiently only by the fully activated Cdk7 complex
GO:0005515 protein binding
IPI
PMID:16327805
Dichotomous but stringent substrate selection by the dual-fu...
REMOVE
Summary: Protein binding (IPI) with a substrate (SUPT5H, CDK4 or CDK2) from the analog-sensitive kinase screen.
Reason: The partners are substrates, captured by the kinase activity annotations. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
Supporting Evidence:
PMID:16327805
proteins such as Pol II and transcription elongation factor Spt5, recognized efficiently only by the fully activated Cdk7 complex
GO:0005515 protein binding
IPI
PMID:16327805
Dichotomous but stringent substrate selection by the dual-fu...
REMOVE
Summary: Protein binding (IPI) with a substrate (SUPT5H, CDK4 or CDK2) from the analog-sensitive kinase screen.
Reason: The partners are substrates, captured by the kinase activity annotations. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
Supporting Evidence:
PMID:16327805
proteins such as Pol II and transcription elongation factor Spt5, recognized efficiently only by the fully activated Cdk7 complex
GO:0005515 protein binding
IPI
PMID:22939624
Quantitative analysis of HSP90-client interactions reveals p...
REMOVE
Summary: Protein binding (IPI) with HSP90AA1.
Reason: This is a chaperone-client interaction from a proteome-scale HSP90 study. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005515 protein binding
IPI
PMID:23393140
Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CD...
MODIFY
Summary: Protein binding (IPI) with CtBP2 and cyclin H (CCNH).
Reason: The interaction set includes cyclin H, the activating cyclin of CDK7; the informative molecular function is cyclin binding. The CtBP2 association is recorded under the protein stabilization row.
Proposed replacements: cyclin binding
Supporting Evidence:
PMID:23393140
the cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) complex interacted with CtBP2 in vivo and in vitro
PMID:15530371
For maximum activity and stability, CDK7 requires phosphorylation, association with cyclin H, and association with a third protein, MAT1
GO:0005515 protein binding
IPI
PMID:23455922
Interlaboratory reproducibility of large-scale human protein...
REMOVE
Summary: Protein binding (IPI) with CDK2.
Reason: High-throughput AP-MS of kinases; CDK2 is a CAK substrate. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005515 protein binding
IPI
PMID:23602568
The protein interaction landscape of the human CMGC kinase g...
REMOVE
Summary: Protein binding (IPI) with SRPK2 or SRPK1.
Reason: High-throughput AP-MS of the CMGC kinase group; no CDK7 function follows from it. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005515 protein binding
IPI
PMID:23602568
The protein interaction landscape of the human CMGC kinase g...
REMOVE
Summary: Protein binding (IPI) with SRPK2 or SRPK1.
Reason: High-throughput AP-MS of the CMGC kinase group; no CDK7 function follows from it. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
REMOVE
Summary: Protein binding (IPI) with HSP90AA1.
Reason: Proteome-scale interactome data (BioPlex). Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
REMOVE
Summary: Protein binding (IPI) with SRPK2 or SRPK1.
Reason: Proteome-scale kinase interaction network. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005515 protein binding
IPI
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Ro...
REMOVE
Summary: Protein binding (IPI) with SRPK2 or SRPK1.
Reason: Proteome-scale kinase interaction network. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: Protein binding (IPI) with HSP90AA1.
Reason: Proteome-scale interactome data. Bare protein binding is uninformative, so under the repository protein-binding policy the row is removed; this does not dispute that the interaction was observed.
GO:0005524 ATP binding
IEA
GO_REF:0000002
ACCEPT
Summary: ATP binding inferred from the protein kinase domain.
Reason: CDK7 is an active protein kinase; the crystal structure was solved with bound ATP and UniProt maps the ATP-binding residues in the glycine-rich loop.
Supporting Evidence:
PMID:15530371
We have determined the crystal structure of human CDK7 in complex with ATP at 3 A resolution
GO:0005634 nucleus
EXP
PMID:15695176
Cyclin-dependent kinase activating kinase/Cdk7 co-localizes ...
ACCEPT
Summary: Nuclear localization by confocal co-localization with PKC-iota in glioma cells.
Reason: CDK7 functions in the nucleus as part of TFIIH and the CAK complex; the C-terminal KRKR motif targets it there.
Supporting Evidence:
PMID:15695176
Confocal microscopy revealed the co-localization of PKC-iota with CAK/cdk7 in both the cytoplasm and nucleus of U-373 MG cells
PMID:7936635
the wild-type protein is detected exclusively in the nucleus
GO:0005634 nucleus
EXP
PMID:19071173
DNA-Bound peptides control the mRNA transcription through CD...
ACCEPT
Summary: Nuclear localization reported in a study of barley DNA-bound peptides acting via CDK7.
Reason: The paper's main claim (peptide-induced translocation) is weak and condition-specific, but the nuclear location of CDK7 itself is well established, so the location annotation stands.
Supporting Evidence:
PMID:19071173
The DNA-Bound peptides also significantly inhibited in vitro and in vivo DNA transcription activity by regulating the expression and the corresponding functions of CDK7
PMID:7936635
the wild-type protein is detected exclusively in the nucleus
GO:0005634 nucleus
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference that CDK7 is active in the nucleus.
Reason: Nuclear activity is inferred from a deep CDK node (PTN000623091) and is consistent with direct evidence for human CDK7.
Supporting Evidence:
PMID:7936635
the wild-type protein is detected exclusively in the nucleus
GO:0005634 nucleus
IDA
PMID:10958787
Interactions of Cdk7 and Kin28 with Hint/PKCI-1 and Hnt1 his...
ACCEPT
Summary: Nuclear localization of CDK7 (Hint partner study).
Reason: CDK7 functions in the nucleus as part of TFIIH and the CAK complex; the C-terminal KRKR motif targets it there.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7936635
the wild-type protein is detected exclusively in the nucleus
GO:0005634 nucleus
IDA
PMID:16109376
The bromodomain protein Brd4 is a positive regulatory compon...
ACCEPT
Summary: Nuclear localization of CDK7 (MGI-curated, Brd4/P-TEFb study).
Reason: CDK7 functions in the nucleus as part of TFIIH and the CAK complex; the C-terminal KRKR motif targets it there.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7936635
the wild-type protein is detected exclusively in the nucleus
GO:0005634 nucleus
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic nucleus annotation.
Reason: CDK7 functions in the nucleus as part of TFIIH and the CAK complex; the C-terminal KRKR motif targets it there.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
GO:0005634 nucleus
TAS
PMID:7936635
Cloning, expression and subcellular localization of the huma...
ACCEPT
Summary: Nuclear localization of tagged human MO15/CDK7.
Reason: Wild-type CDK7 is detected exclusively in the nucleus and nuclear targeting is required for CAK activity.
Supporting Evidence:
PMID:7936635
the wild-type protein is detected exclusively in the nucleus
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
IEA
GO_REF:0000107
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-109639
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-111264
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-112379
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-112383
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-112385
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-113430
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-170076
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-170087
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-187949
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-188350
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-5689861
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-5691000
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6781818
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6781824
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6781833
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6781840
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6781867
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782004
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782069
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782131
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782138
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782141
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782204
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782208
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782211
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782224
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782227
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6782234
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6797606
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6797616
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6810233
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6810234
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6810235
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6810238
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6814549
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6814555
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6814559
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-6814885
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-73758
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-73769
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-73946
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-74986
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-74992
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-74993
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-74994
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75850
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75856
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75861
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75862
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75864
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75866
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75869
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75873
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75891
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-75949
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-76576
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77068
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77069
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77071
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77073
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77077
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77078
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77081
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77083
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77085
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-77090
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8942836
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9613494
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9613497
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9684118
ACCEPT
Summary: CDK7 located in the nucleoplasm.
Reason: CDK7 acts in the nucleoplasm as the TFIIH/TFIIK kinase on promoter-bound RNA polymerase II and as the CAK. The many Reactome reactions place TFIIH (and therefore CDK7) in the nucleoplasm across Pol II, snRNA, Pol I and TC-NER events; the location is correct irrespective of whether CDK7 is catalytic in each individual reaction.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10958787,
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005675 transcription factor TFIIH holo complex
IDA
PMID:9852112
Immunoaffinity purification and functional characterization ...
ACCEPT
Summary: CDK7 in the TFIIH holo complex (immunopurified FLAG-TFIIH).
Reason: CAK (CDK7-cyclin H-MAT1) is the kinase module of holo-TFIIH.
Supporting Evidence:
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
PMID:9852112
The purified complexes are functional in mediating basal and activated transcription
GO:0005675 transcription factor TFIIH holo complex
IEA
GO_REF:0000002
ACCEPT
Summary: Electronic TFIIH holo complex annotation.
Reason: CDK7 is a stoichiometric TFIIH component via the CAK module.
Supporting Evidence:
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005675 transcription factor TFIIH holo complex
IPI
PMID:15220921
A new, tenth subunit of TFIIH is responsible for the DNA rep...
ACCEPT
Summary: ComplexPortal TFIIH holo complex membership.
Reason: Consistent with purification of CAK within TFIIH.
Supporting Evidence:
PMID:15220921
Here, we describe the identification of the human TFB5 ortholog and its association with human TFIIH
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
GO:0005737 cytoplasm
EXP
PMID:15695176
Cyclin-dependent kinase activating kinase/Cdk7 co-localizes ...
KEEP AS NON CORE
Summary: Cytoplasmic CDK7 in glioma cells co-localizing with PKC-iota.
Reason: A fraction of CDK7 is cytoplasmic (free CAK); the functional pool is nuclear, so this is a minor location.
Supporting Evidence:
PMID:15695176
Confocal microscopy revealed the co-localization of PKC-iota with CAK/cdk7 in both the cytoplasm and nucleus of U-373 MG cells
GO:0005737 cytoplasm
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic inference of cytoplasmic activity.
Reason: The IBA derives from PAINT node PANTHER:PTN000624096, the eukaryote-wide CDK7 ortholog clade of PTHR24056 (members include S. cerevisiae Kin28, S. pombe Mcs6 [SPBC19F8.07], Drosophila Cdk7 and rat Cdk7); human CDK7 sits inside this clade (UniProt PTHR24056:SF0) and has its own experimental support, so its appearance among the donors is expected, not circular. A fraction of CDK7 is cytoplasmic (free CAK); the functional pool is nuclear, so this is a minor location.
Supporting Evidence:
PMID:15695176
Confocal microscopy revealed the co-localization of PKC-iota with CAK/cdk7 in both the cytoplasm and nucleus of U-373 MG cells
GO:0005737 cytoplasm
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: Cytoplasm from UniProt subcellular location mapping.
Reason: A fraction of CDK7 is cytoplasmic (free CAK); the functional pool is nuclear, so this is a minor location.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
ECO:0000269|PubMed:15695176, ECO:0000269|PubMed:19071173}. Cytoplasm
GO:0005829 cytosol
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: HPA immunofluorescence cytosol signal.
Reason: A fraction of CDK7 is cytoplasmic (free CAK); the functional pool is nuclear, so this is a minor location.
Supporting Evidence:
PMID:15695176
Confocal microscopy revealed the co-localization of PKC-iota with CAK/cdk7 in both the cytoplasm and nucleus of U-373 MG cells
GO:0006289 nucleotide-excision repair
NAS
PMID:22572993
TFIIH: when transcription met DNA repair.
MARK AS OVER ANNOTATED
Summary: Nucleotide-excision repair attributed to CDK7 from a TFIIH review.
Reason: TFIIH participates in NER through its core helicases XPB/XPD, but the CAK subcomplex is released from TFIIH when XPA binds the lesion (Reactome R-HSA-5689861), and the cited review is about TFIIH as a whole. CDK7 does not perform an NER step; the annotation transfers a complex-level process to the kinase module.
Supporting Evidence:
PMID:22572993
The transcription initiation factor TFIIH is a remarkable protein complex that has a fundamental role in the transcription of protein-coding genes as well as during the DNA nucleotide excision repair pathway
Reactome:R-HSA-5689861
Binding of XPA is accompanied by the release of the CAK subcomplex from the TFIIH complex
GO:0006366 transcription by RNA polymerase II
TAS
Reactome:R-HSA-73857
MODIFY
Summary: Reactome 'RNA Polymerase II Transcription' for CDK7.
Reason: Correct but general. CDK7's direct role is CTD Ser5/Ser7 phosphorylation at promoters during initiation and promoter escape; the specific process term is already carried by the gene.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive
PMID:26257281
Inhibition of Cdk7 blocks Pol II CTD phosphorylation during initiation
GO:0006367 transcription initiation at RNA polymerase II promoter
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference of Pol II transcription initiation.
Reason: The IBA derives from PAINT node PANTHER:PTN000624096, the eukaryote-wide CDK7 ortholog clade of PTHR24056 (members include S. cerevisiae Kin28, S. pombe Mcs6 [SPBC19F8.07], Drosophila Cdk7 and rat Cdk7); human CDK7 sits inside this clade (UniProt PTHR24056:SF0) and has its own experimental support, so its appearance among the donors is expected, not circular. CDK7, as the TFIIH kinase, phosphorylates the CTD of promoter-bound Pol II during initiation; THZ1 inhibition blocks this initiation-associated phosphorylation.
Supporting Evidence:
PMID:26257281
Inhibition of Cdk7 blocks Pol II CTD phosphorylation during initiation
GO:0006367 transcription initiation at RNA polymerase II promoter
IDA
PMID:26257281
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping an...
ACCEPT
Summary: Transcription initiation: THZ1 inhibition of CDK7 blocks CTD phosphorylation during initiation.
Reason: CDK7, as the TFIIH kinase, phosphorylates the CTD of promoter-bound Pol II during initiation; THZ1 inhibition blocks this initiation-associated phosphorylation.
Supporting Evidence:
PMID:26257281
Inhibition of Cdk7 blocks Pol II CTD phosphorylation during initiation
GO:0006367 transcription initiation at RNA polymerase II promoter
IDA
PMID:7533895
Cdk-activating kinase complex is a component of human transc...
ACCEPT
Summary: Transcription initiation: anti-CDK7 antibodies block CTD phosphorylation in the preinitiation complex.
Reason: CDK7, as the TFIIH kinase, phosphorylates the CTD of promoter-bound Pol II during initiation; THZ1 inhibition blocks this initiation-associated phosphorylation.
Supporting Evidence:
PMID:7533895
both cyclin H and Cdk7 antibodies inhibit phosphorylation of the CTD of the largest subunit of the RNAPII in the preinitiation complex
GO:0006367 transcription initiation at RNA polymerase II promoter
IDA
PMID:8692841
Isolation and characterization of two human transcription fa...
ACCEPT
Summary: Transcription initiation: ERCC2/CAK stimulates TFIIH*-dependent transcription.
Reason: CDK7, as the TFIIH kinase, phosphorylates the CTD of promoter-bound Pol II during initiation; THZ1 inhibition blocks this initiation-associated phosphorylation.
Supporting Evidence:
PMID:8692841
This TFIIH*-dependent transcription reaction was stimulated by ERCC2/CAK
GO:0006367 transcription initiation at RNA polymerase II promoter
NAS
PMID:22572993
TFIIH: when transcription met DNA repair.
ACCEPT
Summary: Transcription initiation (TFIIH review).
Reason: CDK7, as the TFIIH kinase, phosphorylates the CTD of promoter-bound Pol II during initiation; THZ1 inhibition blocks this initiation-associated phosphorylation.
Supporting Evidence:
PMID:22572993
The transcription initiation factor TFIIH is a remarkable protein complex that has a fundamental role in the transcription of protein-coding genes as well as during the DNA nucleotide excision repair pathway
PMID:26257281
Inhibition of Cdk7 blocks Pol II CTD phosphorylation during initiation
GO:0006367 transcription initiation at RNA polymerase II promoter
TAS
PMID:7533895
Cdk-activating kinase complex is a component of human transc...
ACCEPT
Summary: Transcription initiation (TAS, CAK in TFIIH).
Reason: CDK7, as the TFIIH kinase, phosphorylates the CTD of promoter-bound Pol II during initiation; THZ1 inhibition blocks this initiation-associated phosphorylation.
Supporting Evidence:
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
PMID:7533895
both cyclin H and Cdk7 antibodies inhibit phosphorylation of the CTD of the largest subunit of the RNAPII in the preinitiation complex
GO:0008094 ATP-dependent activity, acting on DNA
IDA
PMID:9852112
Immunoaffinity purification and functional characterization ...
REMOVE
Summary: ATP-dependent activity acting on DNA, from functional characterization of immunopurified TFIIH.
Reason: CDK7 is a protein kinase (single kinase domain 12-295, no helicase or DNA-translocase motifs); the DNA-dependent ATPase/helicase activities of TFIIH reside in XPB (ERCC3) and XPD (ERCC2). The cited abstract characterizes the purified TFIIH complex, and the activity was attributed to every subunit. This is a complex-activity transfer to a non-catalytic subunit for this activity.
Supporting Evidence:
PMID:9852112
The purified complexes are functional in mediating basal and activated transcription
PMID:8692841
TFIIH* consists of a subset of the TFIIH complex proteins including ERCC3 (XPB), p62, p44, p41, and p34 but is devoid of detectable levels of ERCC2 (XPD) and CAK
GO:0008353 RNA polymerase II CTD heptapeptide repeat kinase activity
EXP
PMID:26257281
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping an...
ACCEPT
Summary: CTD kinase activity (THZ1 study).
Reason: CDK7 is the TFIIH CTD kinase; chemical-genetic and THZ1 inhibition abolish initiation-associated CTD Ser5/Ser7 phosphorylation.
Supporting Evidence:
PMID:26257281
Inhibition of Cdk7 blocks Pol II CTD phosphorylation during initiation
PMID:26257281
Cdk7 phosphorylates Ser5 and Ser7 residues, the first of several CTD phosphorylation and dephosphorylation events during the transcription cycle
GO:0008353 RNA polymerase II CTD heptapeptide repeat kinase activity
EXP
PMID:28768201
Human TFIIH Kinase CDK7 Regulates Transcription-Associated C...
ACCEPT
Summary: CTD kinase activity (CDK7as cells).
Reason: CDK7 is the TFIIH CTD kinase; chemical-genetic and THZ1 inhibition abolish initiation-associated CTD Ser5/Ser7 phosphorylation.
Supporting Evidence:
PMID:28768201
During transcription initiation, CDK7 phosphorylates the C-terminal domain (CTD) of the pol II subunit RPB1.
PMID:28768201
CDK7 phosphorylates the CTD on Ser5 and Ser7
GO:0008353 RNA polymerase II CTD heptapeptide repeat kinase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference of CTD kinase activity.
Reason: The IBA derives from PAINT node PANTHER:PTN000624096, the eukaryote-wide CDK7 ortholog clade of PTHR24056 (members include S. cerevisiae Kin28, S. pombe Mcs6 [SPBC19F8.07], Drosophila Cdk7 and rat Cdk7); human CDK7 sits inside this clade (UniProt PTHR24056:SF0) and has its own experimental support, so its appearance among the donors is expected, not circular. CDK7 is the TFIIH CTD kinase; chemical-genetic and THZ1 inhibition abolish initiation-associated CTD Ser5/Ser7 phosphorylation.
Supporting Evidence:
PMID:28768201
During transcription initiation, CDK7 phosphorylates the C-terminal domain (CTD) of the pol II subunit RPB1.
GO:0008353 RNA polymerase II CTD heptapeptide repeat kinase activity
IDA
PMID:12721286
A novel RNA polymerase II C-terminal domain phosphatase that...
ACCEPT
Summary: CTD kinase activity: TFIIH-phosphorylated Pol II used as substrate for SCP1.
Reason: TFIIH (via CDK7) phosphorylates CTD Ser5, generating the preferred SCP1 substrate.
Supporting Evidence:
PMID:12721286
The preferred substrate for SCP1 is RNAP II phosphorylated by TFIIH
file:human/CDK7/CDK7-uniprot.txt
II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive
GO:0008353 RNA polymerase II CTD heptapeptide repeat kinase activity
IDA
PMID:9852112
Immunoaffinity purification and functional characterization ...
ACCEPT
Summary: CTD kinase activity of immunopurified TFIIH.
Reason: CDK7 is the TFIIH CTD kinase; chemical-genetic and THZ1 inhibition abolish initiation-associated CTD Ser5/Ser7 phosphorylation.
Supporting Evidence:
PMID:7533895
both cyclin H and Cdk7 antibodies inhibit phosphorylation of the CTD of the largest subunit of the RNAPII in the preinitiation complex
file:human/CDK7/CDK7-uniprot.txt
II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive
GO:0008353 RNA polymerase II CTD heptapeptide repeat kinase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic CTD kinase activity.
Reason: CDK7 is the TFIIH CTD kinase; chemical-genetic and THZ1 inhibition abolish initiation-associated CTD Ser5/Ser7 phosphorylation.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive
GO:0016301 kinase activity
IEA
GO_REF:0000107
MODIFY
Summary: Electronic kinase activity.
Reason: Too general; CDK7 is a cyclin-dependent protein kinase acting on CDKs and the Pol II CTD.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
Catalytic subunit of the CDK-activating kinase (CAK) complex, a master
file:human/CDK7/CDK7-uniprot.txt
II by mediating phosphorylation of POLR2A at 'Ser-5' of the repetitive
GO:0042795 snRNA transcription by RNA polymerase II
TAS
Reactome:R-HSA-6807505
KEEP AS NON CORE
Summary: Reactome snRNA transcription by RNA polymerase II.
Reason: CDK7/TFIIH phosphorylates CTD Ser5 and Ser7 at snRNA promoters, but Reactome notes that loss of CTD phosphorylation impairs pre-snRNA 3' processing rather than snRNA transcription itself. A valid but gene-class-specific context of the core initiation role.
Supporting Evidence:
Reactome:R-HSA-6810233
CDK7 phosphorylates serine-5 residues of heptad repeats (consensus YSPTSPS) in the C-terminal domain (CTD) of the large subunit (POLR2A) of RNA polymerase II
Reactome:R-HSA-6810233
Impairment of CTD phosphorylation does not appear to affect transcription of snRNA genes but rather impairs 3' processing of the pre-snRNA
GO:0045944 positive regulation of transcription by RNA polymerase II
IDA
PMID:9852112
Immunoaffinity purification and functional characterization ...
MARK AS OVER ANNOTATED
Summary: Positive regulation of Pol II transcription from purified TFIIH supporting basal and activated transcription.
Reason: The cited work shows that purified TFIIH complexes support basal and activated transcription; that is participation of a general transcription factor in transcription initiation (already annotated), not a CDK7-specific regulatory activity at particular genes.
Supporting Evidence:
PMID:9852112
The purified complexes are functional in mediating basal and activated transcription
GO:0048471 perinuclear region of cytoplasm
IEA
GO_REF:0000044
MARK AS OVER ANNOTATED
Summary: Perinuclear region from UniProt subcellular location.
Reason: The source observation is relocation of CDK7 after treatment of HeLa cells with barley DNA-bound peptides, a non-physiological condition in a single study; it does not describe where CDK7 normally acts.
Supporting Evidence:
file:human/CDK7/CDK7-uniprot.txt
to cytoplasm and perinuclear region in response to DNA-bound peptides
PMID:19071173
The DNA-Bound peptides also significantly inhibited in vitro and in vivo DNA transcription activity by regulating the expression and the corresponding functions of CDK7
GO:0050821 protein stabilization
IMP
PMID:23393140
Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CD...
KEEP AS NON CORE
Summary: Protein stabilization: CCNH/CDK7 binding protects CtBP2 from proteasomal clearance.
Reason: CCNH/CDK7 binding competes with HIPK2 and blocks CtBP2 phosphorylation and degradation, so the complex does contribute to CtBP2 stabilization. Single-study, cancer-cell context, and peripheral to the CAK and CTD-kinase roles.
Supporting Evidence:
PMID:23393140
Depletion of either CCNH or CDK7 decreased CtBP2 protein levels by accelerating proteasome-dependent CtBP2 clearance
PMID:23393140
CCNH/CDK7 competed with the tumor repressor HIPK2 for CtBP2 binding and consequently inhibited phosphorylation and dimerization of CtBP2
GO:0051726 regulation of cell cycle
IBA
GO_REF:0000033
MODIFY
Summary: Phylogenetic inference of regulation of cell cycle.
Reason: The IBA derives from PAINT node PANTHER:PTN000624096, the eukaryote-wide CDK7 ortholog clade of PTHR24056 (members include S. cerevisiae Kin28, S. pombe Mcs6 [SPBC19F8.07], Drosophila Cdk7 and rat Cdk7); human CDK7 sits inside this clade (UniProt PTHR24056:SF0) and has its own experimental support, so its appearance among the donors is expected, not circular. CDK7 regulates the cell cycle as the CAK, phosphorylating the T-loops of CDK4/6 and CDK2 (G1/S) and CDK1 (G2/M). The general term is true and also entailed by GO:0004693; the evidence supports the specific transitions.
Propagation Review
Root cause: NO FAILURE CORE
Sources checked:
PANTHER:PTN000624096 Β· PTN000624096 SUPPORTS TRANSFER
CDK7 ortholog clade node seeded by human CDK7 and C9K505; regulation of cell cycle is correct for the clade, and the MODIFY only refines it to the G1/S and G2/M transitions supported for human CDK7.
Supporting Evidence:
PMID:23622515
Here we analyze activation of Cdk4 and Cdk6 in Cdk7as cells, and show that Cdk7 is a physiologic CAK for both cyclin D-dependent kinases
PMID:20360007
we find that Cdc25A overexpression leads to an activation of Cdk7 and increase in Thr(161) phosphorylation of Cdk1
GO:0051726 regulation of cell cycle
TAS
PMID:15876871
CAK-Cyclin-dependent Activating Kinase: a key kinase in cell...
MODIFY
Summary: Regulation of cell cycle (review of CAK).
Reason: CDK7 regulates the cell cycle as the CAK, phosphorylating the T-loops of CDK4/6 and CDK2 (G1/S) and CDK1 (G2/M). The general term is true and also entailed by GO:0004693; the evidence supports the specific transitions.
Supporting Evidence:
PMID:15876871
The Cyclin-dependent kinase (CDK) Activating Kinase (CAK) is responsible for the activating phosphorylation of CDK1, CDK2, CDK4 and CDK6 and regulation of the cell cycle
PMID:23622515
this suggests that Cdk7 is a universal CAK for CDKs involved in human cell division
GO:0070516 CAK-ERCC2 complex
IDA
PMID:8692841
Isolation and characterization of two human transcription fa...
ACCEPT
Summary: CAK-ERCC2 complex isolated from HeLa cells.
Reason: The ERCC2/CAK complex cosediments CDK7, cyclin H, MAT1 and XPD.
Supporting Evidence:
PMID:8692841
ERCC2/CAK was isolated as a complex that exhibits CAK activity that cosediments with the three CAK components (cdk7, cyclin H, and p36/MAT1) as well as the ERCC2 (XPD) protein
GO:0070985 transcription factor TFIIK complex
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference of TFIIK complex membership.
Reason: The IBA derives from PAINT node PANTHER:PTN000624096, the eukaryote-wide CDK7 ortholog clade of PTHR24056 (members include S. cerevisiae Kin28, S. pombe Mcs6 [SPBC19F8.07], Drosophila Cdk7 and rat Cdk7); human CDK7 sits inside this clade (UniProt PTHR24056:SF0) and has its own experimental support, so its appearance among the donors is expected, not circular. TFIIK is the CDK7-cyclin H-MAT1 kinase module of TFIIH, which also exists free as CAK.
Supporting Evidence:
PMID:7533895
Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography
PMID:10801852
the C terminus of MAT1 binds to the cdk7 x cyclin H complex and activates the cdk7 kinase activity
GO:0070985 transcription factor TFIIK complex
IDA
PMID:8692841
Isolation and characterization of two human transcription fa...
ACCEPT
Summary: TFIIK complex membership from isolation of ERCC2/CAK.
Reason: TFIIK is the CDK7-cyclin H-MAT1 kinase module of TFIIH, which also exists free as CAK.
Supporting Evidence:
PMID:8692841
ERCC2/CAK was isolated as a complex that exhibits CAK activity that cosediments with the three CAK components (cdk7, cyclin H, and p36/MAT1) as well as the ERCC2 (XPD) protein
GO:0070985 transcription factor TFIIK complex
IEA
GO_REF:0000002
ACCEPT
Summary: Electronic TFIIK complex membership.
Reason: TFIIK is the CDK7-cyclin H-MAT1 kinase module of TFIIH, which also exists free as CAK.
Supporting Evidence:
PMID:10801852
the C terminus of MAT1 binds to the cdk7 x cyclin H complex and activates the cdk7 kinase activity
GO:0070985 transcription factor TFIIK complex
IMP
PMID:23393140
Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CD...
ACCEPT
Summary: TFIIK complex membership supported in the CtBP2 study by CCNH/CDK7 co-dependence.
Reason: The evidence type (IMP) is unusual for complex membership, but the claim that CDK7 is in the CCNH/CDK7 (TFIIK) complex is well established and consistent with the paper.
Supporting Evidence:
PMID:23393140
the cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) complex interacted with CtBP2 in vivo and in vitro
PMID:10801852
the C terminus of MAT1 binds to the cdk7 x cyclin H complex and activates the cdk7 kinase activity
GO:0106310 protein serine kinase activity
EXP
PMID:20360007
Cdc25 phosphatases are required for timely assembly of CDK1-...
ACCEPT
Summary: Protein serine kinase activity (Cdk1 activation study).
Reason: CDK7 phosphorylates serine residues on protein substrates, including p53 Ser33 and the Pol II CTD Ser5/Ser7.
Supporting Evidence:
PMID:20360007
we find that Cdc25A overexpression leads to an activation of Cdk7 and increase in Thr(161) phosphorylation of Cdk1
PMID:9372954
We have mapped a major site of phosphorylation by CAK to Ser-33 of p53 and have demonstrated as well that p53 is phosphorylated at this site in vivo
GO:0106310 protein serine kinase activity
EXP
PMID:9372954
p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependen...
ACCEPT
Summary: Protein serine kinase activity: CAK phosphorylates p53 at Ser33.
Reason: CDK7 phosphorylates serine residues on protein substrates, including p53 Ser33 and the Pol II CTD Ser5/Ser7.
Supporting Evidence:
PMID:9372954
We have mapped a major site of phosphorylation by CAK to Ser-33 of p53 and have demonstrated as well that p53 is phosphorylated at this site in vivo
GO:0106310 protein serine kinase activity
EXP
PMID:9840937
Regulation of CAK kinase activity by p53.
ACCEPT
Summary: Protein serine kinase activity in CAK assays regulated by p53.
Reason: CDK7 phosphorylates serine residues on protein substrates, including p53 Ser33 and the Pol II CTD Ser5/Ser7.
Supporting Evidence:
PMID:9840937
The addition of wild type p53 to the kinase reactions resulted in a significant downregulation of CDK2 phosphorylation and CTD phosphorylation by the CDK activating kinase
PMID:9372954
We have mapped a major site of phosphorylation by CAK to Ser-33 of p53 and have demonstrated as well that p53 is phosphorylated at this site in vivo
GO:0106310 protein serine kinase activity
IEA
GO_REF:0000116
ACCEPT
Summary: Rhea-based protein serine kinase activity.
Reason: CDK7 phosphorylates serine residues on protein substrates, including p53 Ser33 and the Pol II CTD Ser5/Ser7.
Supporting Evidence:
PMID:9372954
We have mapped a major site of phosphorylation by CAK to Ser-33 of p53 and have demonstrated as well that p53 is phosphorylated at this site in vivo
GO:0140836 RNA polymerase II CTD heptapeptide repeat S5 kinase activity
IDA
PMID:26257281
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping an...
ACCEPT
Summary: CTD S5 kinase activity: THZ1 abolishes initiation-associated Ser5 phosphorylation.
Reason: CDK7 is the TFIIH CTD kinase; chemical-genetic and THZ1 inhibition abolish initiation-associated CTD Ser5/Ser7 phosphorylation.
Supporting Evidence:
PMID:26257281
Inhibition of Cdk7 blocks Pol II CTD phosphorylation during initiation
PMID:26257281
Cdk7 phosphorylates Ser5 and Ser7 residues, the first of several CTD phosphorylation and dephosphorylation events during the transcription cycle
GO:2000045 regulation of G1/S transition of mitotic cell cycle
IDA
PMID:23622515
A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progr...
ACCEPT
Summary: Regulation of G1/S transition: CDK7 is the physiological CAK for CDK4/6 and promotes G1 progression.
Reason: Analog-sensitive CDK7 inhibition rapidly abolishes CDK4/CDK6 T-loop phosphorylation, so CDK7 performs the activating step for the G1 CDKs.
Supporting Evidence:
PMID:23622515
Here we analyze activation of Cdk4 and Cdk6 in Cdk7as cells, and show that Cdk7 is a physiologic CAK for both cyclin D-dependent kinases
PMID:23622515
this suggests that Cdk7 is a universal CAK for CDKs involved in human cell division
GO:0032968 positive regulation of transcription elongation by RNA polymerase II
IDA
PMID:28768201
Human TFIIH Kinase CDK7 Regulates Transcription-Associated C...
NEW
Summary: CDK7 promotes the transition to productive elongation by activating CDK9 (P-TEFb) and phosphorylating DSIF/SPT5.
Reason: CDK7 itself does the work: it phosphorylates the CDK9 T-loop and SPT5, and its inhibition increases promoter-proximal pausing and blocks DSIF loading. Comparator check: the CDK7 ortholog Mcs6 in S. pombe carries this process in its review, and CDK9 itself carries it. Not a substrate or necessity-only relationship.
Supporting Evidence:
PMID:28768201
CDK7 phosphorylates the RNA polymerase II (pol II) C-terminal domain CTD and activates the P-TEFb-associated kinase CDK9
PMID:16327805
proteins such as Pol II and transcription elongation factor Spt5, recognized efficiently only by the fully activated Cdk7 complex
PMID:26257281
we conclude that THZ1 leads to reduced pausing and capping both in vitro and in cells

Core Functions

CDK-activating kinase: as the CDK7-cyclin H-MAT1 trimer, phosphorylates the T-loop threonine of CDK1, CDK2, CDK4 and CDK6, licensing their activity for G1/S and G2/M progression.

Supporting Evidence:
  • PMID:23622515
    Here we analyze activation of Cdk4 and Cdk6 in Cdk7as cells, and show that Cdk7 is a physiologic CAK for both cyclin D-dependent kinases
  • PMID:23622515
    this suggests that Cdk7 is a universal CAK for CDKs involved in human cell division
  • PMID:20360007
    we find that Cdc25A overexpression leads to an activation of Cdk7 and increase in Thr(161) phosphorylation of Cdk1
  • PMID:15876871
    The Cyclin-dependent kinase (CDK) Activating Kinase (CAK) is responsible for the activating phosphorylation of CDK1, CDK2, CDK4 and CDK6 and regulation of the cell cycle

TFIIH CTD kinase: within holo-TFIIH, phosphorylates Ser5 (and Ser7) of the RNA polymerase II CTD at promoters during initiation, enabling promoter escape, capping-enzyme recruitment and pausing.

Supporting Evidence:
  • PMID:26257281
    Inhibition of Cdk7 blocks Pol II CTD phosphorylation during initiation
  • PMID:26257281
    Cdk7 phosphorylates Ser5 and Ser7 residues, the first of several CTD phosphorylation and dephosphorylation events during the transcription cycle
  • PMID:28768201
    During transcription initiation, CDK7 phosphorylates the C-terminal domain (CTD) of the pol II subunit RPB1.
  • PMID:7533895
    both cyclin H and Cdk7 antibodies inhibit phosphorylation of the CTD of the largest subunit of the RNAPII in the preinitiation complex

Promotes productive elongation by activating CDK9 (P-TEFb) through T-loop phosphorylation and by phosphorylating DSIF subunit SPT5.

Supporting Evidence:
  • PMID:28768201
    CDK7 phosphorylates the RNA polymerase II (pol II) C-terminal domain CTD and activates the P-TEFb-associated kinase CDK9
  • PMID:16327805
    proteins such as Pol II and transcription elongation factor Spt5, recognized efficiently only by the fully activated Cdk7 complex

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: GO has no specific molecular function for CDK-activating kinase activity (T-loop phosphorylation of another CDK); should a child of GO:0004672 be created so that CAK activity of CDK7, budding-yeast Cak1 and S. pombe Csk1 can be captured distinctly from the cyclin-dependent activity of the substrate CDKs?

Q: Should the GO:0008094 and GO:0000439 rows derived from purified TFIIH be redistributed to the XPB/XPD and core subunits rather than every co-purifying subunit?

Suggested Experiments

Experiment: Use analog-sensitive CDK7 with phosphoproteomics in G1-synchronised cells to separate the contributions of CAK (CDK4/6/2 T-loop) and TFIIH CTD kinase activity to S-phase entry.

Type: chemical genetics / phosphoproteomics

Deep Research

Falcon

(CDK7-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(CDK7-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)